Join to View Full Profile
150 E 58th St25th FlNew York, NY 10155
Phone+1 212-966-3506
Fax+1 212-409-8902
Dr. Alper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Kenneth Alper, MD, is a highly regarded Psychiatrist based in New York, NY, with education from the University of Texas Health Science Center at San Antonio and post-graduation from New York University School of Medicine. He has extensive experience treating conditions such as delusional disorder, bipolar disorders, trichotillomania, whilst employing psychopharmacology. Dr. Alper has made important contributions to the field through numerous noteworthy publications, including pioneering research on the use of psilocybin and LSD in the treatment of alcohol consumption and reports on treating opioid use disorder. He boasts recognition for his work, with consistent inclusion in the Castle Connolly's Top Doctors in the New York Metro Area from 2002 to 2025, and a mention in New York Magazine's Top Doctors in 2010.
Education & Training
NYU Grossman School of MedicineResidency, Psychiatry, 1984 - 1990
The University of Texas Health Science Center at San AntonioClass of 1984
Certifications & Licensure
NY State Medical License 1985 - 2027
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2002-2022
- New York Magazine: Top Doctors Castle Connolly, 2010
Publications & Presentations
PubMed
- 24 citationsPsilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice.Kenneth Alper, Janelle Cange, Ria Sah, Deanna Schreiber-Gregory, Henry Sershen
Frontiers in Pharmacology. 2022-01-01 - 4 citationsCase Report: Famotidine for Neuropsychiatric Symptoms in COVID-19Kenneth Alper
Frontiers in Medicine. 2020-12-23 - 25 citationsLSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J MiceKenneth Alper, Bin Dong, Relish Shah, Henry Sershen, K. Yaragudri Vinod
Frontiers in Pharmacology. 2018-08-31
Press Mentions
Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for AddictionApril 5th, 2021- Austin Clinic Helps Addiction Patients After Using Psychedelic Drug IbogaineDecember 23rd, 2020
Is Psychedelic Healing in Your Genes? A Team of Scientists Seeks to Find OutJanuary 14th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
